81 FR 3807 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 14 (January 22, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 14 (January 22, 2016)
| Page Range | 3807-3809 | |
| FR Document | 2016-01196 |
[Federal Register Volume 81, Number 14 (Friday, January 22, 2016)] [Notices] [Pages 3807-3809] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-01196] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which [[Page 3808]] would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Developmental Brain Disorders Study Section. Date: February 4-5, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA 92101. Contact Person: Pat Manos, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408- 9866, [email protected]. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section. Date: February 4-5, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton La Jolla Hotel, 3299 Holiday Court, La Jolla, CA 92037. Contact Person: Julius Cinque, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cellular Aspects of Diabetes and Obesity. Date: February 9, 2016. Time: 8:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 20892, 301 435-2514, [email protected]. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Pathophysiological Basis of Mental Disorders and Addictions Study Section. Date: February 11-12, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: New Orleans Downtown Marriott at the Convention Center, 859 Convention Center Boulevard, New Orleans, LA 70130. Contact Person: Boris P. Sokolov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301-408-9115, [email protected]. Name of Committee: Oncology 1--Basic Translational Integrated Review Group; Cancer Etiology Study Section. Date: February 11, 2016. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott--Bethesda North, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr. Room 4192, MSC 7806, Bethesda, MD 20892, 301-451-4467, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-15-276: Turkey-US Collaborative Program for Affordable Medical Technologies (R01). Date: February 16, 2016. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301) 435-3504, [email protected]. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Cellular, Molecular and Integrative Reproduction Study Section. Date: February 17-18, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gary Hunnicutt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD 20892, 301-435-0229, [email protected]. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Molecular and Cellular Endocrinology Study Section. Date: February 17-18, 2016. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: John Bleasdale, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6170 MSC 7892, Bethesda, MD 20892, 301-435-4514, [email protected]. Name of Committee: Oncology 1--Basic Translational Integrated Review Group; Tumor Microenvironment Study Section. Date: February 17-18, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Angela Y. Ng, Ph.D., MBA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 20892, 301-435-1715, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Biophysical and Biomechanical Aspects of Embryonic Development. Date: February 17-18, 2016. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Charles Selden, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 5187 MSC 7840, Bethesda, MD 20892, 301-451- 3388, [email protected]. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Chronic Dysfunction and Integrative Neurodegeneration Study Section. Date: February 18-19, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott at the Convention Center, 859 Convention Center Boulevard, New Orleans, LA 70130. Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-435-1785, [email protected]. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Clinical Research and Field Studies of Infectious Diseases Study Section. Date: February 18, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435- 0903, [email protected]. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Synapses, Cytoskeleton and Trafficking Study Section. Date: February 18-19, 2016. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Row Hotel, 2015 Massachusetts Avenue, Washington, DC 20036. Contact Person: Christine A. Piggee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4186, MSC 7850, Bethesda, MD 20892, 301-435-0657, [email protected]. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Neurotransporters, Receptors, and Calcium Signaling Study Section. Date: February 18-19, 2016. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101. Contact Person: Peter B. Guthrie, Ph.D., Scientific Review Officer, Center for [[Page 3809]] Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD 20892, (301) 435-1239, [email protected]. Name of Committee: Cell Biology Integrated Review Group; Molecular and Integrative Signal Transduction Study Section. Date: February 18-19, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Raya Mandler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5134, MSC 7840, Bethesda, MD 20892, (301) 402- 8228, [email protected]. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Myocardial Ischemia and Metabolism Study Section. Date: February 18-19, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Riverwalk Marriott, 207 N. St. Mary's Street, San Antonio, TX 78205. Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301-435- 5575, [email protected]. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Pathogenic Eukaryotes Study Section. Date: February 18-19, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Best Western Tuscan Inn, 425 North Point Street, San Francisco, CA 94133. Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 20892, (301) 435-2306, [email protected]. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. Date: February 18-19, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Michael M. Sveda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301-435-3565, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 15, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016-01196 Filed 1-21-16; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices 3807
information collection requirements information, and whether IHS agreed or information. If the covered entity
contained in the Rule. disagreed with the restriction. Section accepts the requested amendment, in
45 CFR 164.508: This provision 164.522(a)(2) permits a covered entity to whole or in part, the covered entity
requires covered entities to obtain or terminate its agreement to a restriction must inform the individual that the
receive a valid authorization for its use if the individual agrees to or requests amendment is accepted. If the covered
or disclosure of protected health the termination in writing. The form entity denies the requested amendment,
information for other than for treatment, IHS–912–2 ‘‘Request for Revocation of in whole or in part, the covered entity
payment and healthcare operations. Restriction(s)’’ is used to document the must provide the individual with a
Under the provision individuals may agency or individual request to written denial. The form IHS–917
initiate a written authorization terminate a formerly agreed to ‘‘Request for Correction/Amendment of
permitting covered entities to release restriction regarding the use and Protected Health Information’’ will be
their protected health information to disclosure of protected health used to document an individual’s
entities of their choosing. The form information.
IHS–810 ‘‘Authorization for Use or 45 CFR 164.528 and 45 CFR 5b.9(c): request to amend their protected health
Disclosure of Protected Health This provision requires covered entities information and the agency’s decision to
Information’’ is used to document an to permit individuals to request that the accept or deny the request. Completed
individual’s authorization to use or covered entity provide an accounting of forms used in this collection of
disclose their protected health disclosures of protected health information are filed in the IHS medical,
information. information made by the covered entity. health and billing record, a Privacy Act
45 CFR 164.522: Section 164.522(a)(1) The form IHS–913 ‘‘Request for an System of Records Notice. Affected
requires a covered entity to permit Accounting of Disclosures’’ is used to Public: Individuals and households.
individuals to request that the covered document an individual’s request for an Type of Respondents: Individuals.
entity restrict the use and disclosure of accounting of disclosures of their Burden Hours: The table below provides
their protected health information. The protected health information and the for this information collection: Types of
covered entity may or may not agree to agency’s handling of the request. data collection instruments, estimated
the restriction. The form IHS–912–1 45 CFR 164.526: This provision number of respondents, number of
‘‘Request for Restrictions(s)’’ is used to requires covered entities to permit an responses per respondent, average
document an individual’s request for individual to request that the covered burden hour per response, and total
restriction of their protected health entity amend protected health annual burden hour(s).
Number of Average
Number of Total annual
Data collection instrument responses per burden hour
respondents burden hours
respondent per response *
Authorization for Use or Disclosure of Protected Health Information (OMB
Form No. 0917–0030, IHS–810) .................................................................. 210,954 1 10/60 35,159
Request for Restriction(s) (OMB Form No. 0917–0030, IHS–912–1) ............ 214 1 10/60 36
Request for Revocation of Restriction(s) (OMB Form No. 0917–0030, IHS–
912–2) .......................................................................................................... 3 1 10/60 .5
Request for Accounting of Disclosures (OMB Form No. 0917–0030, IHS–
913) .............................................................................................................. 39 1 10/60 6.5
Request for Correction/Amendment of Protected Health Information (OMB
Form No. 0917–0030, IHS–917) .................................................................. 54 1 10/60 9
Total Annual Burden ................................................................................. 211,264 ........................ ........................ 35,211
* For ease of understanding, burden hours are provided in actual minutes.
The total estimated burden for this (e) ways to enhance the quality, DEPARTMENT OF HEALTH AND
collection of information is 35,211 utility, and clarity of the information HUMAN SERVICES
hours. There are no capital costs, being collected; and
operating costs and/or maintenance National Institutes of Health
(f) ways to minimize the public
costs to respondents. burden through the use of automated,
Requests for Comments: Your written Center for Scientific Review; Notice of
electronic, mechanical, or other Closed Meetings
comments and/or suggestions are
technological collection techniques or
invited on one or more of the following Pursuant to section 10(d) of the
other forms of information technology.
points: Federal Advisory Committee Act, as
(a) Whether the information collection Dated: January 13, 2016. amended (5 U.S.C. App.), notice is
activity is necessary to carry out an Robert G. McSwain, hereby given of the following meetings.
agency function; Principal Deputy Director, Indian Health The meetings will be closed to the
(b) whether the agency processes the Service. public in accordance with the
information collected in a useful and [FR Doc. 2016–01208 Filed 1–21–16; 8:45 am] provisions set forth in sections
mstockstill on DSK4VPTVN1PROD with NOTICES
timely fashion; BILLING CODE 4165–16–P
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
(c) the accuracy of the public burden as amended. The grant applications and
estimate (the estimated amount of time the discussions could disclose
needed for individual respondents to confidential trade secrets or commercial
provide the requested information); property such as patentable material,
(d) whether the methodology and and personal information concerning
assumptions used to determine the individuals associated with the grant
estimates are logical; applications, the disclosure of which
VerDate Sep<11>2014 16:59 Jan 21, 2016 Jkt 238001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM 22JAN1](https://thefederalregister.org/doc/81_FR_3821/page/1.svg)
![Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices 3809
Scientific Review, National Institutes of Dated: January 15, 2016. Date: February 23, 2016.
Health, 6701 Rockledge Drive, Room 4182, Anna Snouffer, Time: 11:00 a.m. to 3:00 p.m.
MSC 7850, Bethesda, MD 20892, (301) 435– Deputy Director, Office of Federal Advisory Agenda: To review and evaluate grant
1239, guthriep@csr.nih.gov. Committee Policy. applications.
Name of Committee: Cell Biology Place: National Institutes of Health,
[FR Doc. 2016–01196 Filed 1–21–16; 8:45 am] Neuroscience Center, 6001 Executive
Integrated Review Group; Molecular and
Integrative Signal Transduction Study BILLING CODE 4140–01–P Boulevard, Rockville, MD 20852 (Telephone
Section. Conference Call).
Date: February 18–19, 2016. Contact Person: David I. Sommers, Ph.D.,
Time: 8:00 a.m. to 1:00 p.m. DEPARTMENT OF HEALTH AND Scientific Review Officer, Division of
Agenda: To review and evaluate grant HUMAN SERVICES Extramural Activities, National Institute of
applications. Mental Health, National Institutes of Health,
Place: Bethesda North Marriott Hotel & National Institutes of Health 6001 Executive Blvd., Room 6154, MSC 9606,
Conference Center, Montgomery County Bethesda, MD 20892–9606, 301–443–7861,
Conference Center Facility, 5701 Marinelli National Institute of Mental Health; dsommers@mail.nih.gov.
Road, North Bethesda, MD 20852. Notice of Closed Meetings Name of Committee: National Institute of
Contact Person: Raya Mandler, Ph.D., Mental Health Special Emphasis Panel; Pilot
Scientific Review Officer, Center for Pursuant to section 10(d) of the Effectiveness Trials for Treatment, Preventive
Scientific Review, National Institutes of Federal Advisory Committee Act, as and Services Interventions (R34).
Health, 6701 Rockledge Drive, Room 5134, amended (5 U.S.C. App.), notice is Date: February 23, 2016.
MSC 7840, Bethesda, MD 20892, (301) 402– hereby given of the following meetings. Time: 1:00 p.m. to 5:00 p.m.
8228, rayam@csr.nih.gov. The meetings will be closed to the Agenda: To review and evaluate grant
Name of Committee: Cardiovascular and public in accordance with the applications.
Respiratory Sciences Integrated Review provisions set forth in sections Place: The Dupont Hotel, 1500 New
Group; Myocardial Ischemia and Metabolism Hampshire Avenue NW., Washington, DC
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Study Section. 20036.
as amended. The grant applications and Contact Person: Aileen Schulte, Ph.D.,
Date: February 18–19, 2016.
Time: 8:00 a.m. to 6:00 p.m. the discussions could disclose Scientific Review Officer, Division of
Agenda: To review and evaluate grant confidential trade secrets or commercial Extramural Activities, National Institute of
applications. property such as patentable material, Mental Health, NIH, Neuroscience Center,
Place: Courtyard Riverwalk Marriott, 207 and personal information concerning 6001 Executive Blvd., Room 6140, MSC 9608,
N. St. Mary’s Street, San Antonio, TX 78205. individuals associated with the grant Bethesda, MD 20892–9608, 301–443–1225,
Contact Person: Kimm Hamann, Ph.D., applications, the disclosure of which aschulte@mail.nih.gov.
Scientific Review Officer, Center for would constitute a clearly unwarranted (Catalogue of Federal Domestic Assistance
Scientific Review, National Institutes of invasion of personal privacy. Program No. 93.242, Mental Health Research
Health, 6701 Rockledge Drive, Room 4118A, Grants, National Institutes of Health, HHS)
MSC 7814, Bethesda, MD 20892, 301–435– Name of Committee: National Institute of
5575, hamannkj@csr.nih.gov. Mental Health Special Emphasis Panel; Dated: January 14, 2016.
Name of Committee: Infectious Diseases NIMH Pathway to Independence Awards Carolyn A. Baum,
(K99). Program Analyst, Office of Federal Advisory
and Microbiology Integrated Review Group;
Date: February 17, 2016. Committee Policy.
Pathogenic Eukaryotes Study Section.
Time: 12:00 p.m. to 4:00 p.m.
Date: February 18–19, 2016. [FR Doc. 2016–01197 Filed 1–21–16; 8:45 am]
Agenda: To review and evaluate grant
Time: 8:30 a.m. to 5:00 p.m.
applications. BILLING CODE 4140–01–P
Agenda: To review and evaluate grant Place: National Institutes of Health,
applications. Neuroscience Center, 6001 Executive
Place: Best Western Tuscan Inn, 425 North Boulevard, Rockville, MD 20852 (Telephone DEPARTMENT OF HEALTH AND
Point Street, San Francisco, CA 94133. Conference Call).
Contact Person: Tera Bounds, DVM, Ph.D.,
HUMAN SERVICES
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Center for Scientific Review Officer, Division of
Scientific Review, National Institutes of
National Institutes of Health
Extramural Activities, National Institute of
Health, 6701 Rockledge Drive, Room 3198, Mental Health, NIH, Neuroscience Center,
MSC 7808, Bethesda, MD 20892, (301) 435–
National Institute of Mental Health;
6001 Executive Blvd., Room 6140, MSC 9608, Notice of Closed Meeting
2306, boundst@csr.nih.gov. Bethesda, MD 20892–9608, 301–443–9734,
Name of Committee: Genes, Genomes, and millerda@mail.nih.gov. Pursuant to section 10(d) of the
Genetics Integrated Review Group; Molecular Name of Committee: National Institute of Federal Advisory Committee Act, as
Genetics A Study Section. Mental Health Special Emphasis Panel; amended (5 U.S.C. App.), notice is
Date: February 18–19, 2016. Developmental/Early Phase Clinical Trials. hereby given of the following meeting.
Time: 8:30 a.m. to 6:00 p.m. Date: February 18, 2016. The meeting will be closed to the
Agenda: To review and evaluate grant Time: 9:30 a.m. to 5:00 p.m.
applications. public in accordance with the
Agenda: To review and evaluate grant
Place: Renaissance M Street Hotel, 1143 applications.
provisions set forth in sections
New Hampshire Avenue NW., Washington, Place: National Institutes of Health, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
DC 20037. Neuroscience Center, 6001 Executive as amended. The grant applications and
Contact Person: Michael M. Sveda, Ph.D., Boulevard, Rockville, MD 20852 (Telephone the discussions could disclose
Scientific Review Officer, Center for Conference Call). confidential trade secrets or commercial
Scientific Review, National Institutes of Contact Person: David I. Sommers, Ph.D., property such as patentable material,
Health, 6701 Rockledge Drive, Room 1114, Scientific Review Officer Division of and personal information concerning
mstockstill on DSK4VPTVN1PROD with NOTICES
MSC 7890, Bethesda, MD 20892, 301–435– Extramural Activities, National Institute of individuals associated with the grant
3565, svedam@csr.nih.gov. Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
applications, the disclosure of which
(Catalogue of Federal Domestic Assistance
Bethesda, MD 20892–9606, 301–443–7861, would constitute a clearly unwarranted
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, dsommers@mail.nih.gov. invasion of personal privacy.
93.337, 93.393–93.396, 93.837–93.844, Name of Committee: National Institute of Name of Committee: National Institute of
93.846–93.878, 93.892, 93.893, National Mental Health Special Emphasis Panel; Mental Health Initial Review Group; Mental
Institutes of Health, HHS) Longitudinal Study—PTSD. Health Services Research Committee.
VerDate Sep<11>2014 16:59 Jan 21, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM 22JAN1](https://thefederalregister.org/doc/81_FR_3821/page/3.svg)
Document Created: 2016-01-22 01:16:32
Document Modified: 2016-01-22 01:16:32
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 4-5, 2016. | |
| FR Citation | 81 FR 3807 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR